Page 1697 - Hematology_ Basic Principles and Practice ( PDFDrive )
P. 1697

Chapter 93  Late Complications of Hematologic Diseases and Their Therapies  1512.e3


                radiation  for  unfavorable  pediatric  Hodgkin’s  disease.  J  Clin  Oncol   108.  Didcock E, Davies HA, Didi M, et al: Pubertal growth in young adult
                22(22):4541–4550, 2004.                               survivors  of  childhood  leukemia.  J  Clin  Oncol  13(10):2503–2507,
             86.  Bredenfeld  H,  Franklin  J,  Nogova  L,  et al:  Severe  pulmonary  toxic-  1995.
                ity  in  patients  with  advanced-stage  Hodgkin’s  disease  treated  with  a   109.  Katz JA, Pollock BH, Jacaruso D, et al: Final attained height in patients
                modified  bleomycin,  doxorubicin,  cyclophosphamide,  vincristine,   successfully  treated  for  childhood  acute  lymphoblastic  leukemia.
                procarbazine,  prednisone,  and  gemcitabine  (BEACOPP)  regimen  is   J Pediatr 123(4):546–552, 1993.
                probably related to the combination of gemcitabine and bleomycin: a   110.  Cohen  A,  Rovelli  A,  Bakker  B,  et al:  Final  height  of  patients  who
                report of the German Hodgkin’s Lymphoma Study Group. J Clin Oncol   underwent  bone  marrow  transplantation  for  hematological  disorders
                22(12):2424–2429, 2004.                               during childhood: a study by the Working Party for Late Effects-EBMT.
             87.  Armenian  SH,  Landier W,  Francisco  L,  et al:  Long-term  pulmonary   Blood 93(12):4109–4115, 1999.
                function in survivors of childhood cancer. J Clin Oncol 33(14):1592–  111.  Sklar CA, Mertens AC, Walter A, et al: Changes in body mass index and
                1600, 2015.                                           prevalence of overweight in survivors of childhood acute lymphoblastic
             88.  Khurshid  I,  Anderson  LC:  Non-infectious  pulmonary  complications   leukemia:  role  of  cranial  irradiation.  Med  Pediatr  Oncol  35:91–95,
                after bone marrow transplantation. Postgrad Med J 78(919):257–262,   2000.
                2002.                                             112.  Asner S, Ammann RA, Ozsahin H, et al: Obesity in long-term survi-
             89.  Williams  KM,  Chien  JW,  Gladwin  MT,  et al:  Bronchiolitis  obliter-  vors of childhood acute lymphoblastic leukemia. Pediatr Blood Cancer
                ans  after  allogeneic  hematopoietic  stem  cell  transplantation.  JAMA   51(1):118–122, 2008.
                302(3):306–314, 2009.                             113.  Chow EJ, Pihoker C, Hunt K, et al: Obesity and hypertension among
             90.  van Dorp W, van Beek RD, Laven JS, et al: Long-term endocrine side   children  after  treatment  for  acute  lymphoblastic  leukemia.  Cancer
                effects  of  childhood  Hodgkin’s  lymphoma  treatment:  a  review.  Hum   110(10):2313–2320, 2007.
                Reprod Update 18(1):12–28, 2012.                  114.  Oeffinger K, Mertens AC, Sklar CA, et al: Obesity in adult survivors of
             91.  Hancock SL, Cox RS, McDougall IR: Thyroid diseases after treatment   childhood acute lymphoblastic leukemia: a report from the Childhood
                of Hodgkin’s disease. N Engl J Med 325:599–605, 1991.  Cancer Survivor Study. J Clin Oncol 21:1359–1365, 2003.
             92.  Glatstein E, McHardy-Young S, Brast N, et al: Alterations in serum thy-  115.  Lindemulder SJ, Stork LC, Bostrom B, et al: Survivors of standard risk
                rotropin (TSH) and thyroid function following radiotherapy in patients   acute lymphoblastic leukemia do not have increased risk for overweight
                with  malignant  lymphoma.  J  Clin  Endocrinol  Metab  32:833–841,   and obesity compared to non-cancer peers: a report from the Children’s
                1971.                                                 Oncology Group. Pediatr Blood Cancer 62(6):1035–1041, 2015.
             93.  Rosenthal MB, Goldfine ID: Primary and secondary hypothyroidism   116.  Mulder RL, Kremer LC, van Santen HM, et al: Prevalence and risk
                in nasophanryngeal carcinoma. JAMA 236:1591–1593, 1976.  factors of radiation-induced growth hormone deficiency in childhood
             94.  Vogelius IR, Bentzen SM, Maraldo MV, et al: Risk factors for radiation-  cancer survivors: a systematic review. Cancer Treat Rev 35(7):616–632,
                induced  hypothyroidism:  a  literature-based  meta-analysis.  Cancer   2009.
                117(23):5250–5260, 2011.                          117.  Janiszewski PM, Oeffinger KC, Church TS, et al: Abdominal obesity,
             95.  Sklar  C,  Whitton  J,  Mertens  A,  et al:  Abnormalities  of  the  thyroid   liver  fat,  and  muscle  composition  in  survivors  of  childhood  acute
                in  survivors  of  Hodgkin’s  disease:  data  from  the  Childhood  Cancer   lymphoblastic leukemia. J Clin Endocrinol Metab 92(10):3816–3821,
                Survivor Study. J Clin Endocrinol Metab 85:3227–3232, 2000.  2007.
             96.  Sklar C, Boulad F, Small T, et al: Endocrine complications of pediatric   118.  Gurney JG, Ness KK, Sibley SD, et al: Metabolic syndrome and growth
                stem cell transplantation. Front Biosci 6:G17–G22, 2001.  hormone deficiency in adult survivors of childhood acute lymphoblastic
             97.  Metzger  ML,  Howard  SC,  Hudson  MM,  et al:  Natural  history  of   leukemia. Cancer 107(6):1303–1312, 2006.
                thyroid nodules in survivors of pediatric Hodgkin lymphoma. Pediatr   119.  Wallace WH, Thomson  AB,  Kelsey TW: The  radiosensitivity  of  the
                Blood Cancer 46(3):314–319, 2006.                     human oocyte. Hum Reprod 18(1):117–121, 2003.
             98.  Greenfield DM, Wright J, Brown JE, et al: High incidence of late effects   120.  Stillman RJ, Schinfeld JS, Schiff I, et al: Ovarian failure in long-term
                found  in  Hodgkin’s  lymphoma  survivors,  following  recall  for  breast   survivors  of  childhood  malignancy.  Am  J  Obstet  Gynecol  139:62–66,
                cancer screening. Br J Cancer 94(4):469–472, 2006.    1981.
             99.  Robison LL, Nesbit ME, Sather HN, et al: Height of children success-  121.  Hamre  MR,  Robison  LL,  Nesbit  ME,  et al:  Effects  of  radiation  on
                fully treated for acute lymphoblastic leukemia: a report from the late   ovarian function in long-term survivors of childhood acute lympho-
                effects study committee of Children’s Cancer Study Group. Med Pediatr   blastic  leukemia:  a  report  from  the  Childrens  Cancer  Study  Group.
                Oncol 13:14–21, 1985.                                 J Clin Oncol 5(11):1759–1765, 1987.
            100.  Sklar C, Mertens A, Walter A, et al: Final height after treatment for   122.  Quigley  C,  Cowell  C,  Jimenez  M,  et al:  Normal  or  early  develop-
                childhood  acute  lymphoblastic  leukemia:  comparison  of  no  cranial   ment of puberty despite gonadal damage in children treated for acute
                irradiation  with  1800  and  2400  centigrays  of  cranial  irradiation.    lymphoblastic leukemia. N Engl J Med 321(3):143–151, 1989.
                J Pediatr 123:59–64, 1993.                        123.  Rowley MJ, Leach DR, Warner GA, et al: Effect of graded doses of
            101.  Papadakis  V, Tan  C,  Heller  G,  et al:  Growth  and  final  height  after   ionizing radiation on the human testes. Radiat Res 59:665–678, 1974.
                treatment  for  childhood  Hodgkin’s  disease.  J  Pediatr  Hematol  Oncol   124.  Speiser  B,  Rubin  P,  Casarett  G:  Aspermia  following  lower  truncal
                18:272–276, 1996.                                     irradiation in Hodgkin’s disease. Cancer 32(3):692–698, 1973.
            102.  Jaruratanasirikul  S,  Owasith  K,  Wongchanchailert  M,  et al:  Growth   125.  Shamberger RC, Sherins RJ, Rosenberg SA: The effects of postoperative
                patterns and final height of survivors of childhood leukemia. J Pediatr   adjuvant chemotherapy and radiotherapy on testicular function in men
                Endocrinol Metab 17(5):719–726, 2004.                 undergoing  treatment  for  soft  tissue  sarcoma.  Cancer  47(10):2368–
            103.  Sanders JE: Growth and development after hematopoietic cell trans-  2374, 1981.
                plant in children. Bone Marrow Transplant 41(2):223–227, 2008.  126.  Sklar  C:  Reproductive  physiology  and  treatment-related  loss  of  sex
            104.  Bhatia  S,  Constine  LS:  Late  morbidity  after  successful  treatment  of   hormone production. Med Pediatr Oncol 33:2–8, 1999.
                children with cancer. Cancer J 15(3):174–180, 2009.  127.  Sklar CA, Robison LL, Nesbit ME, et al: Effects of radiation on testicu-
            105.  Shalet  SM,  Price  DA,  Beardwell  CG,  et al:  Normal  growth  despite   lar function in long-term survivors of childhood acute lymphoblastic
                abnormalities of growth hormone secretion in children treated for acute   leukemia: a report from the Children Cancer Study Group. J Clin Oncol
                leukemia. J Pediatr 94(5):719–722, 1979.              8(12):1981–1987, 1990.
            106.  Blatt J, Bercu BB, Gillin JC, et al: Reduced pulsatile growth hormone   128.  Shalet  SM,  Horner  A,  Ahmed  SR,  et al:  Leydig  cell  damage  after
                secretion  in  children  after  therapy  for  acute  lymphocytic  leukemia.    testicular irradiation for lymphoblastic leukaemia. Med Pediatr Oncol
                J Pediatr 104:182–186, 1984.                          13(2):65–68, 1985.
            107.  Leiper AD, Stanhope R, Preece MA, et al: Precocious or early puberty   129.  Leiper  AD,  Grant  DB,  Chessells  JM:  Gonadal  function  after  tes-
                and growth failure in girls treated for acute lymphoblastic leukaemia.   ticular  radiation  for  acute  lymphoblastic  leukaemia.  Arch  Dis  Child
                Horm Res 30(2–3):72–76, 1988.                         61(1):53–56, 1986.
   1692   1693   1694   1695   1696   1697   1698   1699   1700   1701   1702